Zura Bio Ltd expected to post a loss of 18 cents a share - Earnings Preview

Reuters11-03

<a href="https://laohu8.com/S/ZURA">Zura Bio</a> Ltd <zura.oq> expected to post a loss of 18 cents a share - Earnings Preview </zura.oq>

Zura Bio Ltd ZURA.OQ ZURA.O is expected to show no change in quarterly revenue when it reports results on November 5 (estimated) for the period ending September 30 2025
LSEG's mean analyst estimate for Zura Bio Ltd is for a loss of 18 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Zura Bio Ltd is $13.50, about 71.6% above its last closing price of $3.84

Previous quarterly performance (using preferred earnings measure in US dollars).

QUARTER ENDING	STARMINESMARTESTIMATE®	LSEG IBES ESTIMATE	ACTUAL	BEAT, MET, MISSED	SURPRISE %
Jun. 30 2025	-0.18	-0.19	-0.17	Beat	9.7
Mar. 31 2025	-0.15	-0.16	-0.19	Missed	-19.8
Dec. 31 2024		-0.16	-0.10	Beat	35.6
Sep. 30 2024	-0.12	-0.12	-0.26	Missed	-110.8
Jun. 30 2024	-0.16	-0.15	-0.17	Missed	-13.5
Mar. 31 2024	-0.22	-0.23	-0.02	Beat	91.4
Dec. 31 2023		-0.23	-0.19	Beat	17.5
Sep. 30 2023	-0.25	-0.25	-0.18	Beat	27.4

This summary was machine generated November 3 at 14:49 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2580110214?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-03 22:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2580110214","market":"us","top_or_hot":-1,"title":"Zura Bio Ltd  expected to post a loss of 18 cents a share - Earnings Preview","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title><a href=\"https://laohu8.com/S/ZURA\">Zura Bio</a> Ltd <zura.oq> expected to post a loss of 18 cents a share - Earnings Preview </zura.oq></title></head><body><ul><li><p>Zura Bio Ltd <span>ZURA.OQ</span> <span>ZURA.O</span> is expected to  show no change in quarterly revenue when it reports  results on November 5 (estimated) for the period ending September 30 2025</p></li><li></li><li><p>LSEG's mean analyst estimate for Zura Bio Ltd is for a loss of 18 cents per share. </p></li><li><p>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 6 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"  </p></li><li><p>The mean earnings estimate of analysts was unchanged in the last three months. </p></li><li><p>Wall Street's median 12-month price target for Zura Bio Ltd is $13.50, about 71.6% above its last closing price of $3.84</p></li></ul><p>Previous quarterly performance (using preferred earnings measure in US dollars). </p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>STARMINESMARTESTIMATE®</p></td><td><p>LSEG IBES ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td><td><p>SURPRISE %</p></td></tr><tr><td><p>Jun. 30 2025</p></td><td><p>-0.18</p></td><td><p>-0.19</p></td><td><p>-0.17</p></td><td><p>Beat</p></td><td><p>9.7</p></td></tr><tr><td><p>Mar. 31 2025</p></td><td><p>-0.15</p></td><td><p>-0.16</p></td><td><p>-0.19</p></td><td><p>Missed</p></td><td><p>-19.8</p></td></tr><tr><td><p>Dec. 31 2024</p></td><td></td><td><p>-0.16</p></td><td><p>-0.10</p></td><td><p>Beat</p></td><td><p>35.6</p></td></tr><tr><td><p>Sep. 30 2024</p></td><td><p>-0.12</p></td><td><p>-0.12</p></td><td><p>-0.26</p></td><td><p>Missed</p></td><td><p>-110.8</p></td></tr><tr><td><p>Jun. 30 2024</p></td><td><p>-0.16</p></td><td><p>-0.15</p></td><td><p>-0.17</p></td><td><p>Missed</p></td><td><p>-13.5</p></td></tr><tr><td><p>Mar. 31 2024</p></td><td><p>-0.22</p></td><td><p>-0.23</p></td><td><p>-0.02</p></td><td><p>Beat</p></td><td><p>91.4</p></td></tr><tr><td><p>Dec. 31 2023</p></td><td></td><td><p>-0.23</p></td><td><p>-0.19</p></td><td><p>Beat</p></td><td><p>17.5</p></td></tr><tr><td><p>Sep. 30 2023</p></td><td><p>-0.25</p></td><td><p>-0.25</p></td><td><p>-0.18</p></td><td><p>Beat</p></td><td><p>27.4</p></td></tr></tbody></table><p>This summary was machine generated November 3 at 14:49 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zura Bio Ltd  expected to post a loss of 18 cents a share - Earnings Preview</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZura Bio Ltd  expected to post a loss of 18 cents a share - Earnings Preview\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-03 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title><a href=\"https://laohu8.com/S/ZURA\">Zura Bio</a> Ltd <zura.oq> expected to post a loss of 18 cents a share - Earnings Preview </zura.oq></title></head><body><ul><li><p>Zura Bio Ltd <span>ZURA.OQ</span> <span>ZURA.O</span> is expected to  show no change in quarterly revenue when it reports  results on November 5 (estimated) for the period ending September 30 2025</p></li><li></li><li><p>LSEG's mean analyst estimate for Zura Bio Ltd is for a loss of 18 cents per share. </p></li><li><p>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 6 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"  </p></li><li><p>The mean earnings estimate of analysts was unchanged in the last three months. </p></li><li><p>Wall Street's median 12-month price target for Zura Bio Ltd is $13.50, about 71.6% above its last closing price of $3.84</p></li></ul><p>Previous quarterly performance (using preferred earnings measure in US dollars). </p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>STARMINESMARTESTIMATE®</p></td><td><p>LSEG IBES ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td><td><p>SURPRISE %</p></td></tr><tr><td><p>Jun. 30 2025</p></td><td><p>-0.18</p></td><td><p>-0.19</p></td><td><p>-0.17</p></td><td><p>Beat</p></td><td><p>9.7</p></td></tr><tr><td><p>Mar. 31 2025</p></td><td><p>-0.15</p></td><td><p>-0.16</p></td><td><p>-0.19</p></td><td><p>Missed</p></td><td><p>-19.8</p></td></tr><tr><td><p>Dec. 31 2024</p></td><td></td><td><p>-0.16</p></td><td><p>-0.10</p></td><td><p>Beat</p></td><td><p>35.6</p></td></tr><tr><td><p>Sep. 30 2024</p></td><td><p>-0.12</p></td><td><p>-0.12</p></td><td><p>-0.26</p></td><td><p>Missed</p></td><td><p>-110.8</p></td></tr><tr><td><p>Jun. 30 2024</p></td><td><p>-0.16</p></td><td><p>-0.15</p></td><td><p>-0.17</p></td><td><p>Missed</p></td><td><p>-13.5</p></td></tr><tr><td><p>Mar. 31 2024</p></td><td><p>-0.22</p></td><td><p>-0.23</p></td><td><p>-0.02</p></td><td><p>Beat</p></td><td><p>91.4</p></td></tr><tr><td><p>Dec. 31 2023</p></td><td></td><td><p>-0.23</p></td><td><p>-0.19</p></td><td><p>Beat</p></td><td><p>17.5</p></td></tr><tr><td><p>Sep. 30 2023</p></td><td><p>-0.25</p></td><td><p>-0.25</p></td><td><p>-0.18</p></td><td><p>Beat</p></td><td><p>27.4</p></td></tr></tbody></table><p>This summary was machine generated November 3 at 14:49 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL8N3WF1FS:1","article_id":"2580110214","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2580110214","pubTimestamp":1762181383,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Zura Bio Ltd  expected to post a loss of18cents a share - Earnings Preview Zura Bio Ltd ZURA.OQ ZURA.O is expected to  show no change in quarterly revenue when it reports  results on November 5 (estim","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ZURA":"Zura Bio"},"translate_title":"Zura Bio Ltd预计每股亏损18美分-收益预览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZURA":0.9},"content_text":"Zura Bio Ltd  expected to post a loss of 18 cents a share - Earnings Preview Zura Bio Ltd ZURA.OQ ZURA.O is expected to  show no change in quarterly revenue when it reports  results on November 5 (estimated) for the period ending September 30 2025LSEG's mean analyst estimate for Zura Bio Ltd is for a loss of 18 cents per share. The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 6 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"  The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Zura Bio Ltd is $13.50, about 71.6% above its last closing price of $3.84Previous quarterly performance (using preferred earnings measure in US dollars). QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATE ACTUALBEAT, MET, MISSEDSURPRISE %Jun. 30 2025-0.18-0.19-0.17Beat9.7Mar. 31 2025-0.15-0.16-0.19Missed-19.8Dec. 31 2024-0.16-0.10Beat35.6Sep. 30 2024-0.12-0.12-0.26Missed-110.8Jun. 30 2024-0.16-0.15-0.17Missed-13.5Mar. 31 2024-0.22-0.23-0.02Beat91.4Dec. 31 2023-0.23-0.19Beat17.5Sep. 30 2023-0.25-0.25-0.18Beat27.4This summary was machine generated November 3 at 14:49 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,preview","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2580110214","isCrawlerRequest":true}